A trial at The Royal Marsden has shown that targeted radiotherapy injections can be of benefit to treatment resistant prostate cancer.

Early results show that the ‘search and destroy’ drug shrank tumours or halted their growth in 83% of patients.

Consultant Johann de Bono said the drug could offer fresh hope to patients who urgently need more effective therapies.

The next stage is to test the method in larger clinical trials.